S-100β protects cultured neurons against glutamate- and staurosporine-induced damage and is involved in the antiapoptotic action of the 5 HT(1A)-receptor agonist, Bay x 3702

Brain Research

Volumn 858, Issue 1, 2000, Pages 121-128

  Ahlemeyer, B ^a   Beier, H ^a   Semkova, I ^a   Schaper, C ^a   Krieglstein, J ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

5 HT(1A) receptor agonist; Bay x 3702; Glutamate; Neuronal cell; Neuroprotection; S 100 ; Staurosporine

Indexed keywords

GLUTAMIC ACID; PROTEIN S 100; REPINOTAN; SEROTONIN 1 AGONIST; STAUROSPORINE; ANTIBODY; BENZOPYRAN DERIVATIVE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; NERVE GROWTH FACTOR; NEUROPROTECTIVE AGENT; PIPERAZINE DERIVATIVE; PYRIDINE DERIVATIVE; S 100 CALCIUM BINDING PROTEIN BETA SUBUNIT; S-100 CALCIUM-BINDING PROTEIN BETA SUBUNIT; SEROTONIN 1 RECEPTOR; SEROTONIN ANTAGONIST; SEROTONIN RECEPTOR; THIAZOLE DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ASTROCYTE; CELL VIABILITY; CHICK EMBRYO; CONTROLLED STUDY; CORPUS STRIATUM; CYTOTOXICITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HIPPOCAMPUS; MALE; NERVE INJURY; NEUROPROTECTION; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT; REVIEW; TELENCEPHALON; ANIMAL; ARTICLE; CELL CULTURE; CELL PROTECTION; CELL SURVIVAL; COCULTURE; CYTOLOGY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; FISCHER 344 RAT; METABOLISM; NERVE CELL; WISTAR RAT;

ANIMALS; ANIMALS, NEWBORN; ANTIBODIES; APOPTOSIS; ASTROCYTES; BENZOPYRANS; CELL SURVIVAL; CELLS, CULTURED; CHICK EMBRYO; COCULTURE TECHNIQUES; CORPUS STRIATUM; CYTOPROTECTION; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUTAMIC ACID; HIPPOCAMPUS; MALE; NERVE GROWTH FACTORS; NEURONS; NEUROPROTECTIVE AGENTS; PIPERAZINES; PYRIDINES; RATS; RATS, INBRED F344; RATS, WISTAR; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT1; S100 PROTEINS; SEROTONIN ANTAGONISTS; STAUROSPORINE; THIAZOLES;

EID: 0033621821     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(99)02438-5     Document Type: Article

References (55)

1. B. Ahlemeyer, J. Krieglstein, Stimulation of 5-HT1A receptors inhibits apoptosis induced by serum deprivation in cultured neurons from chick embryo, Brain Res. 777 (1997) 179-186.
2. B. Ahlemeyer, J. Krieglstein, Retinoic acid reduces staurosporine-in-duced apoptotic damage in chick embryonic neurons by suppressing reactive oxygen species production, Neurosci. Lett. 246 (1998) 93-96.
3. B. Ahlemeyer, A. Glaser, C. Schaper, I. Semkova, J. Krieglstein, The 5-HT1A receptor agonist, Bay x 3702, inhibited apoptosis induced by serum deprivation in cultured neurons, Eur. J. Pharmacol. 370 (1999) 211-216.
4. R. Allore, D. O'Hanlon, R. Price, K. Neilson, D.R. Willard, A. Cox, A. Marks, R.J. Dunn, Gene encoding the beta subunit of S-100 protein is on chromosome 21: implications for Down's syndrome, Science 239 (1988) 1311-1313.
5. E.C. Azmitia, P.M. Whitaker-Azmitia, Awakening the sleeping giant: anatomy and plasticity of the brain serotonergic system, J. Clin. Psychiatry 52 (1991 )4-16.
6. E.C. Azmitia, V.J. Rubenstein, J.A. Strafaci, J.C. Rios, P.M. Whitaker-Azmitia, 5-HT1A agonist and dexamethasone reversal of PCA-induced loss of MAP-2 and synaptophysin immunoreactivity in adult rat brain, Brain Res. 677 (1995) 181-185.
7. S.W. Barger, L.J. Van Eldik, S-100β stimulates calcium fluxes in neuronal and glial cells, J. Biol. Chem. 267 (1992) 9689-9694.
8. S.W. Barger, L.J. Van Eldik, M. Mattson, S-100β protects hip-pocampal neurons from damage induced by glucose deprivation, Brain Res. 677 (1995) 167-170.
9. O. Bar-Peled, R. Gross-Isseroff, H. Ben-Hur, I. Hoskins, Y. Gronerer, A. Biegon, Fetal brain exhibits a prenatal peak in the number of 5-HT1A receptors, Neurosci. Lett. 127 (1991) 173-176.
10. A. Bhattacharyya, R.W. Oppenheim, D. Prevette, B.W. Moore, R. Brackenbury, N. Ratner, S-100 is present in developing chicken neurons and Schwann cells and promotes motor neuron survival in vivo, J. Neurobiol. 23 (1992) 451-466.
11. P. Calissano, A.D. Bangham, Effect of two brain specific proteins (S-100 and 14.3.2)on cation diffusion across artificial lipid membranes, Biochem. Biophys. Res. Commun. 43 (1971 )504-509.
12. B. Cheng, D.G. McMahon, M.P. Mattson, Modulation of calcium current, intracellular calcium levels and cell survival by glucose deprivation and growth factors in hippocampal neurons, Brain Res. 607 (1993)275-285.
13. R. Gerlai, J.M. Wojtowicz, A. Marks, J. Roder, Overexpression of a calcium binding protein, S-100β, in astrocytes impairs synaptic plasticity and spatial learning in transgenic mice, Learn. Mem. 2 (1995) 26-31.
14. A.J. Green, G. Keir, E.J. Thompson, A specific and sensitive ELISA for measuring S-100b in cerebrospinal fluid, J. Immunol. Methods 23 (1997)35-41.
15. A.J. Green, R.J. Harvey, E.J. Thompson, M.N. Rossor, Increased S-100beta in the cerebrospinal fluid of patients with frontotemporal dementia, Neurosci. Lett. 235 (1997)5-8.
16. W.S.T. Griffin, L.C. Stanley, C. Ling, L.M. White, C.L. White, C. Araoz, Brain interleukin-1 and S-100β immunoreactivity elevated in Down's syndrome and Alzheimer's disease, Proc. Natl. Acad. Sci. U.S.A. 86 (1989) 7611-7615.
17. G. Fanò, M.A. Mariggiò, P. Angelella, P. Nicoletti, A. Antonica, S. Fulle, P. Calissano, The S-100 protein causes an increase of intra-cellular calcium and death of PC12 cells, Neuroscience 53 (1993) 919-925.
18. G. Fanò, S. Biocca, S. Fulle, M.A. Mariggiò, S. Belia, P. Calissano, A protein family in search of a function, Prog. Neurobiol. 46 (1995) 71-82.
19. S. Fulle, M.A. Mariggiò, G. Fanò, A.M. Salvatore, D. Mercanti, C. Petrelli, P. Calissano, Activation of brain adenylate cyclase by S-100 protein via a possible interaction with G-proteins, Neurosci. Res. Commun. 10 (1992)37-42.
20. S. Fulle, M.A. Mariggiò, S. Belia, I. Nicoletti, G. Fanò, Nerve growth factor inhibits apoptosis induced by S-100 binding in neuronal PC12 cells, Neuroscience 76 (1997) 159-166.
21. J.H. Haring, A. Hagan, J. Olson, B. Rodgers, Hippocampal serotonin levels influence the expression of S-100β detected by immunocyto-chemistry, Brain Res. 631 (1993) 119-123.
22. K. Hayashi, Y. Hoshida, Y. Horie, K. Takahashi, K. Taguchi, H. Sonobe, Y. Ohtsuki, T. Akagi, Immunohistochemical study on the distribution of alpha and beta subunits of S-100 protein in brain tumors, Acta Neuropathol. 81 (1991 )657-663.
23. M. Herrmann, N. Curio, S. Jost, M.T. Wunderlich, H. Synowitz, C.W. Wallesch, Protein S-100β and neuron-specific enolase as early neurobiochemical markers of the severity of traumatic brain injury, Restor. Neurol. Neurosci. 14 (1999)2-3.
24. J. Hillion, J.B. Dumas Milne-Edwards, J. Catelon, F. de Vitry, F. Gros, M. Hamon, Prenatal developmental expression of rat brain 5-HT1A receptor gene followed by PCR, Biochem. Biophys. Res. Commun. 191 (1993)991-997.
25. D. Kligman, D.P. Marshak, Purification and characterization of a neurite extension factor from bovine brain, Proc. Natl. Acad. Sci. U.S.A. 82 (1985) 7136-7139.
26. J.S. Kim, S.S. Yoon, Y.H. Kim, J.S. Ryu, Serial measurement of interleukin-6, transforming growth factor-β, and S-100 protein in patients with acute stroke, Stroke 27 (1996) 1553-1557.
27. J.Y. Koh, M.B. Wie, B.J. Gwag, S.L. Sensi, L.M.T. Canzoniero, J. Demaro, C. Csernansky, D.W. Choi, Staurosporine-induced neuronal apoptosis, Exp. Neurol. 135 (1995) 153-159.
28. A.J. Krohn, E. Preis, J.H.M. Prehn, Staurosporine-induced apoptosis of cultured rat hippocampal neurons involves caspase-1-like proteases as upstream initiators and increased production of superoxide as a main downstream effector, J. Neurosci. 15 (1998)8186-8197.
29. D. Lewis, T.J. Teyler, Anti-S-100 serum blocks long-term potentia-tion in the hippocampal slice, Brain Res. 38 (1986)159-166.
30. Y. Li, J. Wang, J.G. Sheng, L. Liu, S.W. Barger, R.A. Jones, L. Van Eldik, R.E. Mrak, W.S.T. Griffin, S-100β increases levels of β-amyloid precursor protein and its encoding mRNA in rat neuronal cultures, J. Neurochem. 71 (1998) 1421-1428.
31. J.P. Liu, J.M. Lauder, S-100β and insulin-like growth factor II differentially regulate growth of developing serotonin and dopamine neurons in vitro, J. Neurosci. Res. 33 (1992)248-256.
32. K.D. McCarthy, J. de Vellis, Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue, J. Cell Biol. 85 (1980)890-902.
33. A. Migheli, S. Cordera, C. Bendotti, C. Atzori, R. Piva, D. Schiffer, S-100 beta protein is upregulated in astrocytes and motor neurons in the spinal cord of patients with amyotrophic lateral sclerosis, Neu-rosci. Lett. 12 (1999)25-28.
34. U. Missler, M. Wiesmann, C. Friedrich, M. Kaps, S-100 protein and neuron specific enolase concentration in blood as indicators of infarction volume and prognosis in acute ischemic stroke, Stroke 28 (1997)1956-1960.
35. B.W. Moore, A soluble protein characteristic of the nervous system, Biochem. Biophys. Res. Commun. 19 (1965)739-744.
36. R.E. Mrak, J.G. Sheng, W.S.T. Griffin, Correlation of astrocytic S-100β expression with dystrophic neurites in amyloid plaques of Alzheimer's disease, J. Neuropathol. Exp. Neurol. 55 (1996)273-279.
37. M. Otto, E. Bahn, J. Wiltfang, I. Boekhoff, W. Beuche, Decrease of S-100 beta protein in serum of patients with amyotrophic lateral sclerosis, Neurosci. Lett. 16 (1998) 171-173.
38. B. Pettmann, J.C. Louis, M.C.L. Sensenbrenner, Morphological and biochemical maturation of neurones cultured in the absence of glial cells, Nature 281 (1979)378-380.
39. J.H.M. Prehn, M. Welsch, C. Backhauß, J. Nuglisch, F. Ausmeier, C. Karkoutly, J. Krieglstein, Effects of serotonergic drugs in experimental brain ischemia: evidence for a protective role of serotonin in cerebral ischemia, Brain Res. 630 (1993) 110-120.
40. J.H.M. Prehn, J. Krieglstein, Reactive oxygen species in excitotoxic and apoptotic neuronal degeneration, in: J. Krieglstein (Ed.), Pharmacology of Cerebral Ischemia, MedPharm, Stuttgart, 1996, pp. 233-242.
41. R.H. Selinfreund, S.W. Barger, W.J. Pledger, L.J. Van Eldik, Neu-rotrophic protein S-100b stimulates glial proliferation, Proc. Natl. Acad. Sci. U.S.A. 88 (1991 )3554-3558.
42. I. Semkova, P. Wolz, J. Krieglstein, Neuroprotective effect of 5-HT1A receptor agonist, Bay x 3702, demonstrated in vitro and in vivo, Eur. J. Pharmacol. 359 (1998) 251-260.
43. J.G. Sheng, R.E. Mrak, W.S.T. Griffin, S-100β protein expression in Alzheimer's disease: potential role in the pathogenesis of neuritic plaques, J. Neurosci. Res. 39 (1994) 398-404.
44. J.G. Sheng, R.E. Mrak, C.R. Rovnaghi, E. Kozlowska, L.J. Van Eldik, W.S.T. Griffin, Human brain S-100β and S-100β mRNA expression increases with age: pathogenic implications for Alzheimer's disease, Neurobiol. Aging 17 (1996) 359-363.
45. B. Suchanek, H. Struppeck, T. Fahrig, The 5-HT1A receptor agonist, Bay x 3702, prevents staurosporine-induced apoptosis, Eur. J. Pharmacol. 355 (1998)95-101.
46. Q. Yang, A. Hamberger, S. Wang, K.G. Haglid, Appearance of neuronal S-100β during development of the brain, Dev. Brain Res. 91 (1996)181-189.
47. L.J. Van Eldik, R.A. Jensen, B.A. Ehrenfried, W.O. Whetsell Jr., Immunohistochemical localization of S-100 beta in human nervous system tumors by using monoclonal antibodies with specificity for the S-100 beta polypeptide, J. Histochem. Cytochem. 34 (1986) 977-982.
48. L.J. Van Eldik, B. Christie-Pope, L.M. Bolin, E.M. Shooter, W.O. Whetsell, Neurotrophic activity of S-100β in cultures of dorsal root ganglia from embryonic chick and fetal brain, Brain Res. 542 (1991 ) 280-285.
49. P.M. Whitaker-Azmitia, E. Azmitia, 3H-5-Hydroxytryptamine binding to brain astroglial cells: differences between intact and homogenized preparations and mature and immature cultures, J. Neurochem. 46 (1986) 1186-1191.
50. P.M. Whitaker-Azmitia, R. Murphy, E.C. Azmitia, Stimulation of astroglial 5-HT1A receptors releases the serotonergic growth factor, protein S-100, and alters astroglial morphology, Brain Res. 497 (1989)80-86.
51. P.M. Whitaker-Azmitia, R. Murphy, E.C. Azmitia, S-100 protein is released from astroglial cells by stimulation of 5-HT1A receptors, Brain Res. 528 (1990) 155-158.
52. P.M. Whitaker-Azmitia, E.C. Azmitia, Astroglial 5-HT1A receptors and S-100β in development and plasticity, Perspect. Dev. Neuro-biol. 2 (1994)233-238.
53. P.M. Whitaker-Azmitia, M. Wingate, A. Borella, R. Gerlai, J. Roder, E.C. Azmitia, Transgenic mice overexpressing the neu-rotrophic factor S-100β show neuronal cytoskeletal and behavioural signs of altered aging processes: implications for Alzheimer's disease and Down's syndrome, Brain Res. 776 (1997)51-60.
54. F. Winningham-Major, J.L. Straecker, S.W. Barger, S. Coats, L.J. Van Eldik, Neurite extension and neuronal survival activities of recombinant S-100β proteins differ in the content and position of cysteine residues, J. Cell Biol. 109 (1989) 3063-3071.
55. D.A. Wiesner, G. Dawson, Staurosporine induces programmed cell death in embryonic neurons and activation of the ceramide pathway, J. Neurochem. 66 (1996) 1418-1425.